Introduction
============

The use of herbal/botanical products worldwide enjoys increasing popularity.[@b1-jir-7-103],[@b2-jir-7-103] It is known that the great variety of plant secondary metabolites are excellent sources for components such as polyphenols, which exhibit antioxidant, anticarcinogenic, antimutagenic, and anti-inflammatory effects.[@b3-jir-7-103]--[@b5-jir-7-103] The understanding of the cellular and molecular mechanisms involved in the inflammatory process has increased in recent decades, and this has permitted the discovery of many promising targets for the development of new bioactive compounds to treat chronic inflammatory diseases.[@b6-jir-7-103]

*Arctium lappa* (AL), commonly known as burdock, has anti-inflammatory,[@b7-jir-7-103] free radical scavenging,[@b8-jir-7-103] antioxidant,[@b9-jir-7-103] and liver[@b10-jir-7-103] and skin[@b11-jir-7-103] protective effects. On lipopolysaccharide (LPS)-stimulated macrophages, arctigenin exhibited potent inhibitory effects on the production of nitric oxide (NO) and the release of tumor necrosis factor α (TNFα) and interleukin 6 (IL6), but not cyclooxygenase 2 (COX2) expression or COX2 activity.[@b12-jir-7-103]

*Camellia sinensis* (CS), as green tea, is a species of plant whose leaves and leaf buds are used to produce the popular tea beverage. It is widely known for its anti-inflammatory effect, and there is growing interest in its cardiovascular health benefits.[@b13-jir-7-103] Green tea and its major ingredient, epigallocatechin gallate, effectively inhibited the release of high mobility group box 1 (HMGB1) in LPS-induced macrophage cultures[@b14-jir-7-103] by promoting its aggregation and autophagic degradation in these cells.[@b15-jir-7-103]

*Echinacea* spp. plant preparations are claimed to have several pharmacological effects, such as immune enhancement, anti-inflammation, and prevention of common cold.[@b16-jir-7-103] Numerous reports have demonstrated that *Echinacea* spp. constituents have inflammation-related bioactivities such as stimulation of cytokine production[@b17-jir-7-103] or inhibition of COX1 or COX2 activity in vitro.[@b18-jir-7-103] Hou et al,[@b19-jir-7-103] in murine macrophages, demonstrated that alkamides significantly inhibited COX2 activity and the LPS-induced expression of COX2, inducible NO synthase (NOS2), and specific cytokines or chemokines.

*Eleutherococcus senticosus* (ES) is used as an immunological modulator in Oriental medicine.[@b20-jir-7-103] It has been used to treat stress-induced physiological changes and various allergic disorders.[@b21-jir-7-103]--[@b23-jir-7-103] However, it is still unclear how it inhibits allergic responses and how effective it is in experimental models. On activated murine macrophage RAW264.7 cells, ES downregulated *NOS2* expression, showing pro-inflammatory action by blocking activation of JNK and Akt signaling pathways.[@b20-jir-7-103]

The beneficial effects of *Panax ginseng* (PG), have been attributed to the biological activities of its constituents, the ginsenosides. Ginseng extracts and ginsenosides have been reported to have anti-inflammatory properties.[@b24-jir-7-103] Ginseng can modulate the generation of inflammatory mediators (such as NO, synthesized by the activity of NOSs[@b25-jir-7-103]) and the phagocytic activity of macrophages.[@b26-jir-7-103]

*Vaccinium myrtillus* (VM) was one of the most frequently used antidiabetic remedies before the discovery of insulin.[@b27-jir-7-103] However, Hou et al[@b28-jir-7-103] demonstrated that delphinidin, one of the five anthocyanidins present in bilberry, suppressed COX2 by blocking MAPK-mediated pathways with the attendant activation of nuclear factor κB (NFκB), activator protein 1 (AP1), and CCAAT-enhancer-binding protein delta (C/EBPδ) in LPS-activated murine macrophage RAW264.7 cells. Moreover, gene expression profiling of inflammatory cell model RAW264.7 treated with bilberry extract was provided, showing that bilberry extracts affected genes related to inflammation and defense.[@b29-jir-7-103]

A broad range of roles of secondary plant metabolites has been identified for several inflammatory cells and for a large number of inflammatory mediators in important pathologies not previously known to be linked to inflammation, such as obesity, atherosclerosis, and cancer.[@b30-jir-7-103],[@b31-jir-7-103] However, evidence exists that nutraceuticals can modulate various inflammatory mediators (eg, cytokines), the production and/or action of second messengers (cGMP, cAMP, protein kinases), the expression of transcription factors (AP1, NFκB), and the expression of key proinflammatory molecules such as NOS2, COX2, interleukin 1β (IL1β) and TNFα, neuropeptides (substance P), and proteases (matrix proteases).[@b6-jir-7-103] Moreover, whereas the NFκB plays an important role as transcription factor in coordinating the expression of proinflammatory genes, the peroxisome proliferator-activated receptor γ (PPARγ) plays an important role in controlling various diseases based on its anti-inflammatory properties.[@b32-jir-7-103],[@b33-jir-7-103] In this regard, expression of PPARγ is not restricted to adipocytes, but is also found in immune cells, such as B and T lymphocytes, monocytes, macrophages, dendritic cells, and granulocytes.[@b34-jir-7-103] All this evidence suggests a role of PPARγ in the control of the inflammatory response with potential therapeutic applications in inflammation-related diseases.[@b35-jir-7-103]

It has been shown that nuclear factor E2-related factor 2 (NFE2L2) is responsible for both constitutive and inducible expression of antioxidant response element-regulated genes,[@b36-jir-7-103] indicating an important protective role in regulating antioxidant and anti-inflammatory cellular responses.

In this regard, the aim of this research was to investigate the molecular activity of AL, CS, *Echinacea angustifolia* (EA), ES, PG, and VM extracts on cell model RAW264.7, in order to investigate their effect in modulating messenger (m)RNA expression of genes involved in the inflammatory process: *TNFα, COX2, IL1β, NFκB1, NFκB2, NOS2, NFE2L2*, and *PPARγ*. RAW264.7 cells were pre-stimulated with H~2~O~2~ to mimic inflammatory conditions and then treated with plant extracts.

Materials and methods
=====================

Plant extracts
--------------

All the extracts were obtained from commercial companies, standardized for the content of bioactive compounds ([Table 1](#t1-jir-7-103){ref-type="table"}). AL was provided by Bayer S.p.A. (Milan, Italy), and CS, EA, ES, PG, and VM were provided by ACEF S.p.a. (Piacenza, Italy). The extracts (50 mg) were dissolved in 1 mL of 10% dimethyl sulfoxide (DMSO), passed through 0.22 μm pore-sized membrane filter (EMD Millipore, Billerica, MA, USA), and kept in the dark at −20°C until further analysis.

Cell culture
------------

RAW264.7 murine macrophages (American Type Culture Collection \[ATCC\], Manassas, VA, USA) were cultured in Dulbecco's Modified Eagle's Medium supplemented with 10% heat-inactivated fetal bovine serum, 2 mM L-glutamine, 100 U/mL penicillin, and 100 μg/mL streptomycin. All reagents were purchased from Euroclone (Milan, Italy). Cells were maintained in humidified air with 5% CO~2~ at 37°C. For all experiments, the cells were grown to approximately 70%--90% confluence and culture medium with 2% heat-inactivated fetal bovine serum was used.[@b37-jir-7-103]

H~2~O~2~ cell treatment
-----------------------

A preliminary assay was performed by treating macrophages with different final concentrations of H~2~O~2~ (50, 100, and 200 μM) diluted in phosphate-buffered saline (PBS) and further diluted in culture medium. The control cells (CTRL) were incubated for 24 hours with the same final amount of \<0.1% DMSO in the culture medium.

This assay was used to identify the concentration of H~2~O~2~ that would be used to induce an inflammatory condition in the subsequent experiments. Cell viability was measured after 30 and 60 minutes of incubation with H~2~O~2~ (50, 100, and 200 μM).

Plant extracts cell treatment
-----------------------------

To test the effect of plant extracts on macrophages, cells were washed with PBS and treated with different doses of plant extract (1, 10, 100, and 200 μg/mL) in a final concentration of \<0.1% DMSO in the culture medium for 24 hours. In addition, a combined effect of each plant extract and H~2~O~2~ was assayed by incubating cells for 60 minutes with H~2~O~2~ (200 μM) and, after washing with PBS, with the specific dose of each plant extract in a final concentration of \<0.1% DMSO in the culture medium for 24 hours. The CTRL were incubated for 24 hours with the same final amount of \<0.1% DMSO in the culture medium.

Cell viability assay
--------------------

To ascertain the cytotoxic effect of H~2~O~2~ and plant extracts, viability of RAW264.7 cells was measured by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) colorimetric assay.[@b11-jir-7-103],[@b38-jir-7-103] For the assay, cells were seeded in a 96-well plate at a density of 2×10^4^ cells/well and left to grow for 24 hours. Per well, 10 μL of MTT reagent was added and the mixture was further incubated for 3 hours. Next, the mixture in each well was removed, and formed formazan crystals were dissolved in 100 μL of DMSO. Optical density measurement of the mixture was performed in a microplate reader (Tecan GENios, Männedorf, Switzerland) at 550 nm. Cell viability was expressed as percentage of each treatment versus the CTRL.

Quantitative reverse transcriptase polymerase chain reaction (qRT-PCR)
----------------------------------------------------------------------

To determine the modulation of H~2~O~2~ on mRNA expression of *IL1β, NFE2L2, NFκB1, NFκB2, PPARγ, NOS2, COX2*, and *TNFα*, qRT-PCR was preliminarily performed on macrophages treated with 50, 100, and 200 μM H~2~O~2~ for 30 and 60 minutes.

In addition, macrophages were treated with 10 μg/mL of each extract for 24 hours after a pre-stimulation using 200 μM H~2~O~2~ for 60 minutes. To determine whether plant extracts had an effect on H~2~O~2~ pre-stimulated cells, the mRNA expression of the same genes was analyzed.

After treatment, cells were washed with cold PBS before total RNA extraction using the RNeasy Plus Mini Kit (Qiagen NV, Venlo, the Netherlands), according to the manufacturer's instructions. Then, complementary (c)DNA was synthesized from the same purified RNA samples according to ImProm-II™ Reverse Transcription System (Promega Corporation, Fitchburg, WI, USA) and using random and oligo(dT)~15~ primers. Briefly, 1 μg of the purified total RNA was denatured by incubating at 70°C for 5 minutes and then placed at 25°C for 5 minutes, 42°C for 60 minutes, and 70°C for 15 minutes.

Primer3 Input software (Whitehead Institute for Biomedical Research, Cambridge, MA, USA)[@b39-jir-7-103] was used to design the primer sequences encoding for *β actin* (*ACTB*)*, glyceralde-hyde-3-phosphate dehydrogenase* (*GAPDH*)*, IL1β, NFE2L2, NFkB1, NFkB2, PPARγ, NOS2, COX2*, and *TNFα* ([Table 2](#t2-jir-7-103){ref-type="table"}). The relative qRT-PCR was performed in triplicate with the Platinum^®^ SYBR^®^ Green qPCR SuperMix-UDG with ROX (Life Technologies, Carlsbad, CA, USA) on CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories Inc., Hercules, CA, USA). Reaction mixes were prepared with 200 nM of each primer pair ([Table 2](#t2-jir-7-103){ref-type="table"}) and the cDNA (10 ng) added last. Differences between samples and controls were calculated using the 2^−ΔΔCt^ method,[@b40-jir-7-103],[@b41-jir-7-103] where 2^−ΔΔCt^ represents the difference of a given target gene in H~2~O~2~-treated cells versus the CTRL ([Table 3](#t3-jir-7-103){ref-type="table"}) and each sample treated with plant extract versus H~2~O~2~-treated cells ([Figure 1](#f1-jir-7-103){ref-type="fig"}). The expression of target genes was normalized using *ACTB* and *GAPDH*, and ΔCts were calculated by the difference between Ct of the gene target and the geometric mean of the two housekeeping genes. The n-fold expression of a given target gene was calculated as log~2~ (2^−ΔΔCt^).

Statistical analysis
--------------------

Cell viability data related to H~2~O~2~ treatments and computed as % mean ± standard error (SE), were analyzed using the analysis of variance (ANOVA) model to assess the significance of doses (50, 100, and 200 μM H~2~O~2~) and time of treatments (30 minutes and 60 minutes). The effect of plant extracts on cell viability was analyzed using the ANOVA model. The differences in cell viability were analyzed among doses (1, 10, 100, and 200 μg/mL) of each extract. Means were compared adjusting the *P*-values with Bonferroni correction for multiple comparisons (Statistical Package for the Social Sciences \[SPSS\] Version 16.0; SPSS Inc., Chicago, USA).

Relative gene expression data, after H~2~O~2~ treatments, were analyzed using the general linear model to assess the significance of doses (50, 100, and 200 μM H~2~O~2~) and time of treatments (30 minutes and 60 minutes). Expression data are reported as a mean of log~2~(n-fold) ± SE. Means were compared adjusting *P*-values with Bonferroni correction for multiple comparisons (SPSS Version 16.0; SPSS Inc.).

The effect of plant extracts on gene expressions, computed as log~2~(n-fold), were checked by the general linear model. The differences within each gene were analyzed among different extracts. Data were reported as mean of log~2~(n-fold) ± SE. For mean comparisons, the *P*-values were adjusted with Bonferroni correction for multiple comparisons (SPSS Version 16.0; SPSS Inc.).

Results
=======

Cell viability
--------------

To analyze the effect of dose and time of H~2~O~2~ exposure, a preliminary cell viability assay was performed by treating macrophages with increasing doses of H~2~O~2~ from 1 to 200 μM at two times of incubation (30 minutes and 60 minutes). Cell viability (% versus CTRL) after exposure for 30 minutes and 60 minutes slowly decreased, remaining at over 60% (*P*\<0.001) up to 200 μM (67.89%±1.66%) ([Table 4](#t4-jir-7-103){ref-type="table"}). The dose of 200 μM of H~2~O~2~ was chosen to evoke inflammation for 60 minutes without affecting the cell viability (see also the next paragraph).

In addition, cells were treated for 24 hours with plant extracts ([Table 5](#t5-jir-7-103){ref-type="table"}). A concentration of 10 μg/mL of each AL, CS, EA, ES, PG, and VM significantly (*P*\<0.001) reduced cell viability in comparison to the CTRL, remaining, nevertheless, over 80%. On the contrary, concentrations of 100 and 200 μg/mL led to a strong decrease (*P*\<0.001) in viability. Based on this evidence, 10 μg/mL of each plant extract was chosen for the further experiments.

H~2~O~2~ upregulates mRNA expression of inflammatory genes in macrophages
-------------------------------------------------------------------------

As shown in [Table 3](#t3-jir-7-103){ref-type="table"}, the H~2~O~2~ treatment induced the upregulation of all genes, except *PPARγ*, at both incubation times. In particular, the mRNA expression of *NFkB1, NFkB2, COX2*, and *NFE2L2* significantly increased (*P*\<0.001) after 60 minutes of incubation. *TNFα* expression was significantly induced at *P*\<0.05. The mRNA expression of *COX2* was also significantly (*P*\<0.001) upregulated in a concentration-dependent manner. The mRNA expression of *TNFα, NFkB1, NFkB2*, and *NFE2L2* showed a similar trend, at *P*\<0.01. The interaction between time and dose of incubation was significant in the expression of *COX2* (*P*\<0.001) and *NFkB2, NOS2*, and *NFE2L2* (*P*\<0.05). The relative expression of *IL1β* and *PPARγ* did not present any significant variation between doses, times of incubation, or in the interaction between time and dose. Taken together, these results show that 60 minutes of exposure and a concentration of 200 μM were significantly more effective than the other times or concentrations in stimulating the mRNA expression, and therefore were chosen for the further experiments.

Plant extracts modulate the expression of cytokines in pretreated H~2~O~2~ macrophages
--------------------------------------------------------------------------------------

As shown in [Figure 1](#f1-jir-7-103){ref-type="fig"}, all of the treatments significantly (*P*\<0.001) modulated the mRNA expression of each gene, but with some specific effect. AL showed an increase of *NOS2, NFE2L2*, and *PPARγ* expression, while depressing the expression of *TNFα, IL1β, COX2, NFkB1*, and *NFkB2*. CS stimulated *COX2, NFE2L2*, and *PPARγ*, and negatively modulated *TNFα, IL1β, NOS2, NFκB1*, and *NFκB2*. EA and ES upregulated all genes except *IL1β* and *PPARγ*. PG and VM caused a decreased expression of all genes apart from *NFE2L2* and *PPARγ*, which were stimulated.

Discussion
==========

Epidemiological studies have provided convincing evidence that natural dietary compounds possess many biological activities against various chronic inflammatory diseases.[@b42-jir-7-103],[@b43-jir-7-103] In the present study, we evaluated the effect of AL, CS, EA, ES, PG, and VM extracts on the expression of relevant genes involved in inflammatory response. The analyses were performed on macrophages, key cells of immunity mechanisms.[@b44-jir-7-103] In particular, these cells are essential in the shift of the immune response from the so-called type 1 response with cytotoxic effector cells toward the type 2 response that is characterized by antibody production. Previous studies have been commonly conducted on LPS-induced macrophages, while, in this paper, macrophages were stimulated by direct addition of H~2~O~2~. In fact, H~2~O~2~ acts as a secondary messenger in diverse stimuli, which are also not infective, that activate NFκB.[@b45-jir-7-103] In this study, the data demonstrated that 200 μM of H~2~O~2~ affects cell viability similarly to lower doses. Moreover, the choice of 200 μM H~2~O~2~ is a good compromise between the doses that activate inflammatory mediators, such as NFκB, and those naturally produced in the inflammatory process.[@b46-jir-7-103] In fact, the addition of 200 μM H~2~O~2~ for 60 minutes on RAW264.7 cells significantly stimulated the transcription of *TNFα, COX2, NFkB1, NFkB2, NOS2*, and *NFE2L2*. Interestingly, no differences were found between times of exposure and doses in *IL1β* and *PPARγ* expression. H~2~O~2~ clearly stimulated the expression of NFκB-dependent genes in RAW264.7 cells, likely induced by proinflammatory cytokine TNFα, as already observed in MCF-7 cells.[@b47-jir-7-103],[@b48-jir-7-103] Moreover, it is known that several proteins can be oxidized and thus modified by H~2~O~2~. These redox-regulated proteins include transcription factors such as p53, Jun, Fos, and the p50 subunit of NFκB (NFkB1). The oxidation of these proteins can either prevent (*p53, Jun, Fos*) or stimulate (*p50*) the transcriptional activity of these genes.[@b49-jir-7-103]

The plant extract treatments on pre-stimulated macrophages showed an anti-inflammatory action, downregulating inflammatory genes that typically can activate NFκB1 and NFκB2 pathways, as previously observed.[@b12-jir-7-103],[@b50-jir-7-103]

Flavonoids, which specifically affect the modulation of inflammatory gene expression and the function of enzymes critically involved in inflammation,[@b51-jir-7-103],[@b52-jir-7-103] are also present in AL,[@b53-jir-7-103] CS,[@b54-jir-7-103] PG,[@b55-jir-7-103] and VM.[@b56-jir-7-103]

Zhao et al,[@b12-jir-7-103] using LPS to stimulate RAW264.7 cells, demonstrated a block in NO production after addition of the active compound arctigenin. Moreover, the major polyphenol in CS extracts, epigallocatechin gallate, has been recently found to suppress *NOS2* mRNA and protein expression in macrophages[@b57-jir-7-103] through the inhibition of the activation of *NFκB*.[@b58-jir-7-103] In the present study, *NOS2* was upregulated by AL, and by up to twofold by EA and ES, in comparison to the control. CS downregulated *NOS2* expression related to the control, possibly through inhibition of *NFκB1* and *NFκB2*, but without any significant difference compared to other compounds. In general, controversial data could be due to the different extraction solvent, stimulant (LPS or H~2~O~2~), and different active compounds present in the extract.

Anthocyanins, from bilberry (VM), constitute the major bioactive components responsible for the observed downregulating effects on genes involved in inflammatory response, as already observed in a microarray study.[@b29-jir-7-103] Among the tested extracts, VM showed the highest anti-inflammatory activity, as also reported in LPS-stimulated human monocytic cell line by downregulating all the proinflammatory genes, in particular *COX2* and *NOS2*.[@b59-jir-7-103] It has previously been shown that, in murine RAW264.7 cells, anthocyanidins inhibited LPS-induced *COX2* expression by blocking MAPK pathways with the attendant activation of NFκB, C/EBPδ, and AP1.[@b28-jir-7-103]

EA and ES seem to act as immunostimulating agents, downregulating *IL1β* only. It is known that *Echinacea spp*. plant extract has been used for immunomodulation,[@b60-jir-7-103] but the evidence supporting its therapeutic potential is still controversial. In vitro studies have shown that the commercial preparations of *Echinacea spp*. extract stimulate cytokine production by human peripheral blood macrophages[@b17-jir-7-103] and enhance NK cell function and antibody-dependent cytotoxicity of peripheral blood mononuclear cells.[@b61-jir-7-103],[@b62-jir-7-103] In the present study, EA caused an upregulation of *NFkBs, TNFα*, and *COX2*. An enhanced release of cytokines (such as TNFα and interferon-γ) in response to *Echinacea spp*. components was also detectable in rat spleen macrophage.[@b60-jir-7-103] The existing results suggest that the *Echinacea spp*. preparations are potentially effective in stimulating an in vitro and in vivo nonspecific immune response.[@b63-jir-7-103],[@b64-jir-7-103]

Similarly to EA, ES downregulated *IL1β* only. Previous reports indicated that the isolated compounds from ES inhibit the NOS2 as well as COX2 expression.[@b65-jir-7-103],[@b66-jir-7-103] However, it has also been shown that 80% ethanol extract from ES attenuated LPS-induced NOS2 expression but not COX2 expression.[@b20-jir-7-103] Dissimilar results may be due to efficacy according to concentration between whole extract and its derived compounds. On the other hand, EA and ES are the only extracts that downregulated the expression of *PPARγ*, therefore promoting the expression of inflammatory mediators. The PPARγ, a member of the nuclear hormone receptor superfamily, is essential for adipocyte differentiation and glucose homeostasis. PPARγ has been found to regulate macrophage activation in response to mitogens and inflammation,[@b67-jir-7-103] and it was recognized as a negative regulator of the inflammatory activation of both macrophage and T-cells.[@b68-jir-7-103] Christensen et al[@b69-jir-7-103] demonstrated that, on 3T3-L1 adipocytes, various fatty acids and alkylamides from the flowers of *Echinacea purpurea* at high concentrations activated PPARγ. An involvement of PPARγ in the inhibition of IL2 secretion by T-cells in response to EA alkylamides has also been observed.[@b70-jir-7-103] Interestingly, only EA and ES did not stimulate the expression of *PPARγ*, and this was in agreement with the attendant overexpression of the proinflammatory genes.

EA and ES, as well as AL, CS, PG, and VM, upregulated *NFE2L2*, a transcriptional regulator of antioxidant enzymes with an important role in attenuating oxidative stress associated with diseases.[@b71-jir-7-103] CS has been shown to activate NFE2L2 in HL-1 murine cardiomyocytes and to induce phase II enzymes through the antioxidant response element and concomitant protection against H~2~O~2~.[@b72-jir-7-103] Furthermore, echinacoside, one of the major active compounds in EA,[@b73-jir-7-103] resulted in strong activation of NFE2L2 in HaCaT cells, providing a potential skin protection.[@b74-jir-7-103] Interestingly, in the present study, phytochemical treatments modulated the *NFE2L2* expression, which was increased by the oxidant treatment.

Conclusion
==========

Although the important role that H~2~O~2~ plays as an intracellular messenger is not well understood, it is known that local H~2~O~2~ concentration in extracellular fluids during inflammatory processes are sufficient to activate the NFκB pathway, thereby allowing induction of the synthesis of cytokines and other inflammatory mediators. The stimulation of H~2~O~2~ on RAW264.7 cells induced the transcription of proinflammatory mediators, showing that this could be an applicable system by which to activate macrophages. The extracts from AL, CS, PG, and VM decreased the expression of proinflammatory genes on H~2~O~2~-induced RAW264.7 cells in vitro, while EA and ES, on the contrary, promoted these inflammatory mediators.

The promising anti-inflammatory molecular mechanisms of plant extracts in macrophages of murine RAW264.7 cells require validation in future in vivo dietary intervention studies.
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![messengerRNA expression of *TNFα*, *IL1β*, *COX2*, *NOS2*, *NFκB1*, *NFκB2*, *NFE2L2*, and *PPARγ* in RAW264.7 cells treated with 10 μg/ml of each extract for 24 hours after a pre-stimulation using 200 μM H~2~O~2~ for 1 hour relative to H~2~O~2~-treated cells.\
**Notes:** (**A**) *TNFα*; (**B**) *IL1β*; (**C**) *COX2*; (**D**) *NOS2*; (**E**) *NFκB1*; (**F**) *NFκB2*; (**G**) *NFE2L2*; (**H**) *PPARγ*. To compare the bioactivities between six plant extracts for each gene, the general linear model was used with fixed effect for extracts. Bars represent the log~2~(n-fold) mean ± standard error (n=4). The effect of plant extracts for each gene are indicated with different capital letters denoting significant differences at *P*\<0.001.\
**Abbreviations:** AL, *Arctium lappa*; CS, *Camellia sinensis*; EA, *Echinacea angustifolia*; ES, *Eleutherococcus senticosus*; PG, *Panax ginseng*; VM, *Vaccinium myrtillus; COX2, cyclooxygenase 2; IL1β, interleukin 1β ; NFE2L2, nuclear factor E2-related factor 2; NFκB, nuclear factor κB; NOS2, nitric oxide synthase 2; PPARγ, proliferator-activated receptor γ; TNFα, tumor necrosis factor α*.](jir-7-103Fig1){#f1-jir-7-103}

###### 

Abbreviation, botanical name, used part, and yield of extract of each screened plant

  Extract abbreviations   Botanical name                 Used part   Origin                       Content (HPLC method)                                Extract yield (volume/volume)   
  ----------------------- ------------------------------ ----------- ---------------------------- ---------------------------------------------------- ------------------------------- -----
  AL                      *Arctium lappa*                Root        Italy                        40% arctigenin                                       100                             --
  CS                      *Camellia sinensis*            Leaf        Asia                         ≥95% polyphenols, ≥70% catechins total (≥40% EGCG)   --                              100
  EA                      *Echinacea angustifolia*       Root        Italy                        ≥4% echinacoside                                     20                              80
  ES                      *Eleutherococcus senticosus*   Root        Asia                         2% eleutherosides                                    50                              50
  PG                      *Panax ginseng*                Root        People's Republic of China   ≥30% ginsenosides tot                                50                              50
  VM                      *Vaccinium myrtillus*          Fruit       Italy                        ≥25% anthocyanins                                    40                              60

**Abbreviations:** EGCG, epigallocatechin gallate; HPLC, high-performance liquid chromatography.

###### 

Primer pair sets and parameters used in the real time polymerase chain reaction analysis

  -------------------------------------------------------------------------------------------------------------------
  Gene       GenBank accession number   Sequence (5′ → 3′)             Product length (bp)   Primer (nM)   Tan (°C)
  ---------- -------------------------- ------------------------------ --------------------- ------------- ----------
  *COX2*     AK134081                   For: CCCACAGTCAAAGACACTCA\     189                   200           57
                                        Rev: CTCATCACCCCACTCAGGA                                           

  *IL1β*     AK225002                   For: GACCTTCCAGGATGAGGACA\     183                   200           58
                                        Rev: AGCTCATATGGGTCCGACAG                                          

  *NFE2L2*   BC152371                   For: GGTTATCACAGCTGCCTG\       253                   200           56
                                        Rev: GGTAGTTCTGGGACATGG                                            

  *NFκB1*    AK090099                   For: CTGACCTGAGCCTTCTGGAC\     177                   200           59
                                        Rev: GCAGGCTATTGCTCATCACA                                          

  *NFκB2*    AK144994                   For: TGACTGTGGAGCTGAAGTGG\     153                   200           58
                                        Rev: GGTGTGTTTCCAGCAAAGGT                                          

  *NOS2*     M87039                     For: CACCTTGGAGTTCACCCAGT\     170                   200           59
                                        Rev: ACCACTCGTACTTGGGATGC                                          

  *PPARγ*    U01841                     For: GAGCTGACCCAATGGTTG\       232                   200           57
                                        Rev: ACCCTTGCATCCTTCACAAG                                          

  *TNFα*     AK155964                   For: CGAGTGACAAGCCTGTAGCC\     209                   200           60
                                        Rev: GTGGGTGAGGAGCACGTAGT                                          

  *ACTB*     NM_007393                  For: CACCAACTGGGACGACATGGAG\   203                   200           59
                                        Rev: GGCCTGGATGGCCACGTACAT                                         

  *GAPDH*    NM_008084                  For: AATGTGTCCGTCGTGGATCTGA\   117                   200           60
                                        Rev: AGTGTAGCCCAAGATGCCCTTC                                        
  -------------------------------------------------------------------------------------------------------------------

**Abbreviations:** For, forward; Rev, reverse; Tan, annealing temperature; *COX2, cyclooxygenase 2; IL1β, interleukin 1β; NFE2L2, nuclear factor E2-related factor 2; NFκB, nuclear factor κB; NOS2, nitric oxide synthase 2; PPARγ, proliferator-activated receptor γ; TNFα, tumor necrosis factor α; ACTB*, *β actin; GAPDH, glyceraldehyde-3-phosphate dehydrogenase*.

###### 

messengerRNA expression of *TNFα*, *IL1β*, *NFκB1*, *NFκB2*, *NOS2*, *COX2*, *NFE2L2*, and *PPARγ* in RAW264.7 cells treated with 50, 100, and 200 μM of H~2~O~2~ for 30 and 60 minutes in comparison to control cells

  Gene       Dose (μM)   30 minutes   60 minutes   Mean squared error   Time    Dose    Time × dose
  ---------- ----------- ------------ ------------ -------------------- ------- ------- -------------
  *TNFα*     50          0.88         0.98         0.225                0.012   0.009   0.207
  100        1.07        1.81                                                           
  200        1.39        2.52                                                           
  *IL1β*     50          1.23         0.86         0.405                0.817   0.746   0.551
  100        1.21        1.36                                                           
  200        1.08        1.52                                                           
  *NFκB1*    50          0.89         1.56         0.464                0.000   0.008   0.124
  100        1.05        3.03                                                           
  200        1.57        3.89                                                           
  *NFκB2*    50          0.97         1.74         0.114                0.000   0.002   0.044
  100        1.17        2.33                                                           
  200        1.36        3.23                                                           
  *NOS2*     50          0.91         1.15         0.342                0.35    0.266   0.025
  100        1.69        1.53                                                           
  200        0.43        2.3                                                            
  *COX2*     50          0.55         1.69         0.096                0.000   0.000   0.000
  100        0.21        2.6                                                            
  200        0.79        4.05                                                           
  *NFE2L2*   50          0.13         2.73         0.206                0.000   0.002   0.013
  100        2.03        3.16                                                           
  200        0.85        3.70                                                           
  *PPARγ*    50          −0.56        −0.61        0.108                0.694   0.150   0.956
  100        −0.72       −0.73                                                          
  200        −0.92       −1.04                                                          

**Notes:** Data are presented as the log~2~(n-fold) mean ± standard error (n=3). The significance of time of incubation (30 and 60 minutes) and doses, and of the interaction between time × dose (determined by the analysis of variance), are reported.

**Abbreviations:** *COX2, cyclooxygenase 2; IL1β, interleukin 1β; NFE2L2, nuclear factor E2-related factor 2; NFκB, nuclear factor κB; NOS2, nitric oxide synthase 2; PPARγ, proliferator-activated receptor γ; TNFα, tumor necrosis factor α*.

###### 

Cell viability of RAW264.7 cells treated with 50, 100, and 200 μg/ml of H~2~O~2~ for 30 and 60 minutes

  ----------------------------------------------------
  Concentration\   30 minutes        60 minutes
  (μg/mL)                            
  ---------------- ----------------- -----------------
  0                100.00^A^±0.00    100.00^A^±0.00

  50               86.24^A,B^±1.42   84.38^A,B^±1.75

  100              78.06^B^±1.17     73.23^B^±3.15

  200              76.03^B^±0.23     67.89^B^±1.66
  ----------------------------------------------------

**Notes:** Data are presented as % mean ± standard error (n=6). Different superscript letters indicate significant (*P*\<0.001) effects of doses within times of incubation.

**Abbreviation:** SE, standard error.

###### 

Cell viability of RAW264.7 cells treated with 1, 10, 100, and 200 μg/ml plant extracts for 24 hours

  Extract   Concentration (μg/mL)                                   
  --------- ----------------------- --------------- --------------- ---------------
  AL        98.82^A^±1.64           97.78^A^±1.73   56.34^B^±0.86   44.46^C^±1.16
  CS        95.97^A^±0.00           89.14^A^±0.00   56.95^B^±0.00   32.97^C^±0.00
  EA        95.98^A^±1.50           93.88^A^±1.22   74.14^B^±3.19   39.36^C^±1.63
  ES        89.31^A^±0.93           86.59^A^±1.44   55.81^B^±1.39   34.66^C^±1.44
  PG        94.21^A^±1.44           87.48^A^±1.52   55.48^B^±1.80   54.44^B^±0.90
  VM        99.00^A^±1.12           95.53^A^±2.33   77.95^B^±1.08   49.12^C^±1.08

**Notes:** Data are presented as % mean ± standard error (n=6). Different superscript letters indicate significant differences (*P*\<0.001) within treatments at different concentrations (within each row).

**Abbreviations:** AL, *Arctium lappa*; CS, *Camellia sinensis*; EA, *Echinacea angustifolia*; ES, *Eleutherococcus senticosus*; PG, *Panax ginseng*; SE, standard error; VM, *Vaccinium myrtillus*.
